Correlation Between Crossject and Quantum Genomics

Can any of the company-specific risk be diversified away by investing in both Crossject and Quantum Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crossject and Quantum Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Crossject and Quantum Genomics SA, you can compare the effects of market volatilities on Crossject and Quantum Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crossject with a short position of Quantum Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crossject and Quantum Genomics.

Diversification Opportunities for Crossject and Quantum Genomics

-0.03

Correlation Coefficient

Crossject  Quantum Genomics

Good diversification

The 3 months correlation between Crossject and Quantum is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Crossject and Quantum Genomics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantum Genomics and Crossject is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crossject are associated (or correlated) with Quantum Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantum Genomics has no effect on the direction of Crossject i.e., Crossject and Quantum Genomics go up and down completely randomly.

Pair Corralation between Crossject and Quantum Genomics

Assuming the 90 days trading horizon Crossject is expected to under-perform the Quantum Genomics. But the stock apears to be less risky and, when comparing its historical volatility, Crossject is 7.67 times less risky than Quantum Genomics. The stock trades about -0.04 of its potential returns per unit of risk. The Quantum Genomics SA is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  2.62  in Quantum Genomics SA on September 26, 2024 and sell it today you would earn a total of  4.59  from holding Quantum Genomics SA or generate 175.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Crossject  vs.  Quantum Genomics SA

Crossject

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Crossject has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Quantum Genomics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Quantum Genomics SA are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Quantum Genomics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Crossject and Quantum Genomics

The main advantage of trading using opposite Crossject and Quantum Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crossject position performs unexpectedly, Quantum Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantum Genomics will offset losses from the drop in Quantum Genomics' long position.

The idea behind Crossject and Quantum Genomics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.